SENORESUpdated 31 Aug 2026, 5:39

Senores Pharmaceuticals L

SENORESUpdated 31 Aug 2026, 5:39

Market Cap

₹6,826Cr.

Current Price

₹1,482

High / Low

₹1,600/662

Stock P/E

367

ROE2.78%

ROCE4.18%

Book Value₹163

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 2015, Senores Pharmaceuticals Ltd manufactures and develops affordable and high-quality complex generics certified by global food and drugs authorities[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	11	226	464	236	243	263
Inventory Days	31	133	194	121	299	65
Days Payable	12	269	273	310	452	210
Cash Conversion Cycle	30	89	385	47	90	118
Working Capital Days	197	102	-566	-656	105	138
ROCE %	—	5%	6%	3%	2%	4%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 5:39

SENORES PHARMACEUTICALS L (SENORES) financials — quarterly results, P&L, cash flow, balance sheet, shareholding